NEW YORK (GenomeWeb News) – Life Technologies reported after the close of the market Tuesday that its third quarter revenues increased 3 percent year over year, as gains in its research consumables and applied sciences business groups was offset by a decline in its genetic analysis business.

The Carlsbad, Calif.-based maker of genetic analysis products reported total revenues of $935.1 million for the three months ended Sept. 30, up from $911.2 million. Excluding the impact of currency, life Tech said its revenue were up 4 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.